One sentence summary: Our findings suggest that changes in metabolism due to infection or malignancy serve as danger signals and enhance CD1d-mediated NKT-cell responses.
INTRODUCTION
In contrast to the MHC class I restriction that dictates classical T-cell recognition, NKT cells are CD1d restricted. The CD1d molecule is structurally similar to MHC class I, with a three domain α chain that associates non-covalently with β2-microglobulin (β 2 m). However, unlike MHC class I, CD1d has a hydrophobic antigen-binding groove that enables selective binding of glycolipid antigens (East, Kennedy and Webb 2014; Zajonc and Girardi 2015) . Also, in comparison to the relatively ubiquitous expression of MHC class I on almost all eukaryotic cells, CD1d is expressed mainly on dendritic cells, macrophages, B cells and T cells (Salio et al. 2014) .
CD1d-mediated antigen presentation begins with the synthesis of the CD1dα chain in the endoplasmic reticulum (ER) (Barral and Brenner 2007) . Here, chaperones like calnexin, calreticulin and Erp57 help to ensure that it is properly folded (Kang and Cresswell 2002) . The antigen-binding groove of CD1d is occupied by a 'self' lipid thought to be loaded by microsomal triglyceride transfer protein (Dougan et al. 2005) . After association with β 2 m, the CD1d molecule follows the secretory pathway from the ER to the Golgi and reaches the plasma membrane (PM). Studies from our group and others have shown that in order to present an activating endogenous antigen to NKT cells, CD1d molecules must recycle from the PM to endocytic compartments, due primarily to the presence of a CD1d-localized tyrosine-based targeting motif (Jayawardena-Wolf et al. 2001; Chiu et al. 2002; Roberts et al. 2002) that is analogous to the invariant chain (Ii) for MHC class II molecules. In fact, Ii, which mediates trafficking of MHC class II from the Golgi to the lysosomes, can also associate with CD1d; however, the tyrosine-based motif is necessary for the proper recycling of CD1d molecules and their trafficking to endocytic compartments (Sullivan, Nagarajan and Kronenberg 2005) .
Following internalization from the PM, adaptor proteins AP2 and AP3 direct CD1d molecules back to an endocytic compartment, also known as MIIC, where MHC class II molecules are normally loaded with peptide antigens (Cernadas et al. 2003; Elewaut et al. 2003) . Once in the endocytic recycling compartment, the stabilizing self-lipid is exchanged for other activating lipid antigens with the help of saposins (Kang and Cresswell 2004; Zhou et al. 2004) . These loaded CD1d molecules are then re-expressed on the PM and can be recognized by invariant NKT cells. This complex process of CD1d-mediated antigen processing and presentation has several potential levels of control, yet very few endogenous regulatory factors for this process have been identified.
Some of the factors known to be important for CD1d-mediated antigen processing and presentation are the mitogenactivated protein kinases (MAPK), PKCδ and Rho kinases (Renukaradhya et al. 2005 (Renukaradhya et al. , 2008 Brutkiewicz et al. 2007; Gallo et al. 2012) . Altered metabolism is a common feature of both viral infections and cancers, including lymphoma (Platanias and Vakana 2011; Levy and Bartosch 2015; Lovelace and Polyak 2015) . Recently, we reported that overexpression or induction of Bcl-xL in mouse B-cell lymphoma cells results in significantly increased CD1d-mediated antigen presentation. In contrast, knockdown of Bcl-xL leads to a significant decrease in level of the intracellular trafficking of CD1d to LAMP + compartments and a reduction in CD1d-mediated NKT cells activation (Subrahmanyam, Carey and Webb 2014 ). These data demonstrate that Bcl-xL functions to regulate CD1d-mediated antigen presentation by altering intracellular trafficking of CD1d and support the notion that the regulation of intracellular CD1d-mediated antigen presentation may serve as a strategy that can influence host immune recognition of stressed cells. Moreover, these data implicate a role for alterations in cellular bioenergetics in the modulation of antigen processing and presentation. Thus, we hypothesized that changes in metabolism due to infection or malignancy could serve as danger signals and enhance CD1d-mediated NKT-cell responses. Classically, two pathways are thought to exist for NKT-cell activation. An antigen-dependent pathway by which NKT cells are activated through direct recognition of microbial glycolipid antigens via their TCR (Kinjo et al. 2005 (Kinjo et al. , 2006 Mattner et al. 2005; Sriram et al. 2005) and another cytokine-dependent pathway due to the ability of NKT cells to respond to innate or inflammatory stimuli, which may be associated with self-Ag recognition (Brigl et al. 2003; Mattner et al. 2005; Paget et al. 2007; Salio et al. 2007; Brigl and Brenner 2010; Darmoise et al. 2010) . Given the important role that CD1d-specific NKT cells play in many different types of infections, autoimmunity and transplantation, we investigated NKT-cell responses during an acute viral infection and to cancer cells. These two divergent stimuli were potent inducers of cytokine production by NKT cells, and our studies reveal a novel role for the energy sensor AMP-activated protein kinase (AMPK) in regulating CD1d-mediated antigen processing and presentation.
MATERIALS AND METHODS

Peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque (Amersham Pharmacia Biotek, Uppsala, Sweden) density gradient centrifugation. All donors gave written informed consent before enrolling in the study. The Institutional Review Board of University of Maryland School of Medicine (Baltimore, MD) approved this investigation. Human primary B cells were isolated using the Pan B-cell isolation kit from StemCell Technologies according to the manufacturer's instructions. To generate primary human NKT cells, PBMC were purchased from Biological Specialty Corp and the New York Blood Center. NKT cells were isolated and expanded as previously reported (Webb et al. 2012) .
Mice
Male and female C57BL/6 wild-type mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All mice were infected between 6 and 12 weeks of age and were age and sex matched. All experiments were performed in accordance with procedures approved by Indiana University School of Medicine animal use and care committee.
Virus and infection of mice
The Armstrong strain of lymphocytic choriomeningitis virus (LCMV) was provided by Dr R. Welsh (University of Massachusetts Medical Center, Worcester, MA). Viral stocks were prepared in BHK cells as previously described (Spence et al. 2001) . Mice were infected i.p. with 1-2 × 10 5 plaque forming units PFU of LCMV as previously described (Hobbs et al. 2001; Roberts et al. 2004) . On the indicated days post infection (p.i.), thymi and spleens were harvested and cocultured with NKT-cell hybridomas.
Cell lines, antigens and other reagents
The Vα14 + NKT-cell hybridoma cell lines DN32.D3, N38-2C12, N38-3C3 and the Vα5 + CD1d-specific NKT-cell hybridoma N37-1A12 have all been described (Lantz and Bendelac 1994; Brutkiewicz et al. 1995; Roberts et al. 2002) 
Mononuclear cell isolation
Thymi and spleens were harvested from uninfected and LCMVinfected mice and processed into single-cell suspensions. Erythrocytes were lysed by hypotonic shock in 0.84% NH 4 Cl. The remaining cells were washed twice with IMDM supplemented with 5% FBS (complete medium), and then resuspended in the same medium.
NKT cell hybridoma assay
To measure endogenous Ag presentation by CD1d1 molecules, LCD1 cells were infected with LCMV (MOI = 5) for 20 h at 37
The cells were then washed three times in cold PBS. The NKTcell hybridomas (5-10 × 10 4 cells/well) were incubated with 5
× 10 5 target cells for 24 h at 37
• C. Coculture supernatants were harvested, and IL-2 production was measured by ELISA.
Flow cytometry
Cells were stained in PBS containing 0.5% BSA and 2 mM EDTA for 30 min at 4
• C with a PE-conjugated antibody to CD1d (clone 1B1) from BD Biosciences (San Jose, CA). Data were collected on an LSR II from BD Biosciences (San Jose, CA) and analyzed using FCS Express Version 3 from De Novo Software (Los Angeles, CA).
Western blotting
Cells were lysed using lysis buffer containing NaCl (150 mM), Tris-Cl (50 mM), EDTA (8.5 mM), sodium azide (0.02%), NP-40 (0.1%) and complete mini protease inhibitor cocktail tablet from Roche Applied Science (Indianapolis, IN) as directed by the manufacturer, and prepared in water. Proteins were resolved by electrophoresis on a 4%-12% gradient polyacrylamide gel and transferred to a PVDF membrane using the iBlot transfer system (Life Technologies, Carlsbad, CA). All gels, equipment, buffers and other materials were from Life Technologies and were used as per the manufacturer's instructions.
Statistical analyses
Two-tailed student's t test, one-way analysis of variance (ANOVA) or two-way ANOVA were used as appropriate. Specific experimental groups were compared with controls using the Sidak's multiple comparisons test. P value less than 0.05 was considered significant. All analyses were performed using Prism 5.02 by GraphPad (La Jolla, CA). # P < 0.0001, * * * P < 0.001, * * P < 0.01 and * P < 0.05.
RESULTS
LCMV infection induces NKT-cell responses
We have previously reported a dichotomy in NKT-cell responses between different viral infections. Infection with vaccinia virus or vesicular stomatitis virus resulted in a decrease in CD1d-mediated NKT-cell activation, whereas an acute infection with LCMV did not (Renukaradhya et al. 2005) . To further investigate the effects of an acute LCMV infection on CD1d-mediated antigen presentation to NKT cells, LCD1 cells (murine L-cell fibroblasts transfected with the cd1d1 cDNA) or murine thymocytes were infected with LCMV for 90 min, washed and cocultured with a panel of murine NKT-cell hybridomas. The production of IL-2 into the supernatants was used as an indication of CD1d-dependent NKT-cell activation. Following infection with LCMV, there was an increase in NKT-cell activation induced by both LCD1 cells and murine thymocytes, suggesting a virus-induced enhancement in CD1d-mediated antigen presentation ( Fig. 1A  and B ). This increase in NKT-cell responses was due to CDd1-dependent antigen presentation, because infection of control L cells and the NKT-cell hybridomas themselves did not result in an increase in cytokine production by NKT cells (data not shown). Importantly, these observations were made with both canonical (Vα14 + ) and non-canonical NKT cells (Vα5 + ).
To determine whether infection with LCMV could alter CD1d-mediated NKT cells activation in different cell types, we infected the murine dendritic cell line, FSDC, and cocultured these cells with a panel of NKT-cell hybridomas. LCMV infection of FSDC cells resulted in an increase in NKT-cell activation, without an effect on surface CD1d expression ( Fig. 1C and  D) . These data suggest that a viral infection can rapidly modulate the repertoire of endogenous antigens presented by CD1d molecules.
We next investigated whether an acute LCMV infection would alter CD1d-mediated antigen presentation ex vivo. Therefore, C57BL/6 mice were infected with LCMV for the indicated time periods; thymi were then harvested and cocultured with NKT cells. It was found that in vivo infection with LCMV rapidly alters CD1d-mediated antigen presentation ( Fig. 2A and B) . It has been established that stimulation with naïve murine splenocytes do not activate type I NKT cells (Park, Roark and Bendelac 1998) ; however, we found that LCMV infection confers recognition of splenocytes by NKT cells in the absence of exogenous antigen ( Fig. 2A and B) .
It has been reported that cytotoxic T cells can recognize very early, minor changes in virus-infected target cells Jackson, Ada and Tha Hla 1976) ; thus, we examined whether alterations in glycolysis (such as those induced by a virus infection) would enhance CD1d-mediated NKT-cell activation. Hypoxia-inducible factor (HIF) transcription factors play an important role in the metabolic changes that drive cellular adaptation to low oxygen availability. HIF expression can be induced by hypoxia, but also by other stress-associated factors such as infections and cancer (Palazon et al. 2014) . Thus, we hypothesized that induction of HIF-1α or alterations in glycolytic metabolism may the mechanism by which NKT cells are able to distinguish between healthy cells and infected or malignant cells. To examine whether changes in metabolism would alter CD1d-mediated NKT cells, LCD1 cells were incubated with increasing doses of 2DOG, an inhibitor of cellular glycolysis (Zhong et al. 2009 ). It was found that treatment resulted in an increase in CD1d-mediated NKT-cell activation (Fig. 3A and  B) . Due to the variability in cytokine production by the NKTcell hybridomas, these experiments were repeated >7 times and the trend demonstrated a reproducible increase in NKT-cell responses. Likewise, pretreatment with cobalt chloride (CoCl 2 ), which also induces HIF-1α and increases oxidative respiration (Li et al. 2015) , resulted in a concomitant increase in NKT-cell activation ( Fig. 3B and C) . Importantly, CoCl 2 pretreatment did not alter CD1d cell surface expression at any dose examined (Fig. 3D) . Collectively, these data suggest that changes in glucose In other experiments, splenocytes were harvested 1, 2, 3 and 8 days p. i. and in each case were able to stimulate NKT-cell hybridomas in the absence of exogenous antigen. Cytokine release from NKT cells cocultured with uninfected cells was compared to LCMV-infected cells. * * P < 0.01 and * P < 0.05.
metabolism can alert the innate immune response, by inducing CD1d-mediated NKT-cell activation. This induction is likely due to a change in the repertoire of endogenous glycolipid antigens, as there was no detectable increase in CD1d on the cell surface.
Primary cancer cells express HIF-1α and can induce NKT-cell activation
We have found that alterations in metabolism due to treatment with 2DOG and cobalt chloride can enhance CD1d-mediated NKT-cell responses; thus, we hypothesized that this may be a mechanism by which NKT cells also recognize transformed cells. Interestingly, we found that alterations in glucose metabolism, either by inhibiting glycolysis or inducing HIF-1, resulted in enhanced NKT-cell activation (Fig. 3A-C) . We confirmed this using a panel of human B-cell lymphoma following treatment with CoCl 2 -induced HIF-1α (Fig. 4A) . Moreover, and in agreement with a prior study (Argyriou et al. 2011) , we found that HIF-1α was also highly expressed in malignant B cells isolated from a patient with lymphoma (NHL B cells) (Fig. 4A) . To investigate whether human NKT cells can recognize primary nonHodgkin's lymphoma (NHL) cells, B cells were isolated from the peripheral blood of healthy donors and patients with active disease. When cocultured in the presence of the NKT-cell agonist α-galactosylceramide (α-GalCer), stimulation with lymphoma cells induced higher levels of IFN-γ production by human primary One experiment performed in triplicate, representative of three independent experiments, is shown. (B) Levels of both p-AMPK and AMPK were found to increase in a time-dependent fashion following treatment with AICAR. GAPDH was included as a loading control. (C) Pretreatment with AICAR increases CD1d-mediated NKTcell activation. C1R-CD1D B-cell lymphoblasts were pretreated with 0 or 1000 μM AICAR, A79665 or metformin in the presence or absence of 100 ng mL −1 α-GalCer for 2 h, washed and then cocultured with primary human NKT cells. Cytokine release was measured by ELISA. Data shown are from one experiment of two similar experiments performed in triplicate. # P < 0.0001, * * * P < 0.001, * * P < 0.01 and * P < 0.05.
NKT cells, compared to healthy B cells (Fig. 4B ) (Li et al. 2014) . Collectively, these data suggest that the upregulation of HIF-1α expression by malignant B cells may modulate CD1d-mediated activation of NKT cells.
Induction of AMPK results in increased CD1d-mediated antigen presentation
AMPK serves as a fuel-sensing enzyme that is activated by the binding of AMP and subsequent phosphorylation by upstream kinases, such as the tumor suppressor liver kinase B1 (LKB1), when cells sense an increase in the ratio of AMP to ATP (Flavin, Zadra and Loda 2011) . Acute activation of AMPK stimulates fatty acid oxidation to generate more ATP and simultaneously inhibits ATP-consuming processes, including fatty acid and protein syntheses. This preserves energy for acute cell-surviving program; in contrast, chronic activation leads to inhibition of cell growth. Studies have shown that AMPK is rapidly activated in vitro by both physiological and pathophysiological low-oxygen conditions (Grahame Hardie 2014). We sought to investigate whether activation of AMPK would have an impact on CD1d-mediated antigen presentation to NKT cells. CD1d expressing cells were pretreated with 5-aminoimidazole-4-carboxamide 1-D-ribonucleoside (AICAR), the prototypical AMPK activator and then cocultured with NKT cells. As shown in Fig. 5A , we found that AMPK activation significantly increases CD1d-mediated NKT cell activation. We confirmed AMPK induction by AICAR by western blot (Fig. 5B ). To confirm a role for AMPK activation in being an important regulator of CD1d-mediated NKT-cell responses overall (i.e. not just in murine fibroblasts), we treated the human B lymphoblastoid cell line, C1R-CD1D, with metformin, AICAR or another AMPK activator-A769665. Importantly, the activation of AMPK alone induced NKT-cell activation to levels comparable to stimulation of cells treated with the potent NKT-cell agonist, α-GalCer (Fig. 5C ). These data demonstrate that AMPK activation significantly increases CD1d-mediated NKT-cell activation, and further suggests that NKT cells may be uniquely sensitive to changes in glycolytic respiration, as a mechanism used by the innate immune system to control neoplastic transformation and initiate antiviral immune responses.
DISCUSSION
In this study, we sought to ascertain the mechanisms by which NKT cells recognize virally infected and malignant cells. We found that NKT cells produce higher levels of cytokine when cocultured with LCMV-infected cells or primary B-cell lymphomas, compared to healthy, uninfected control cells. IFN-γ -associated metabolic changes have been observed during viral infection (Wikoff et al. 2009 ) and during malignancy (Flavin, Zadra and Loda 2011) . Thus, we subsequently examined the effect of alterations in metabolism on CD1d-mediated Ag presentation to NKT cells. Pretreatment with 2DOG, cobalt chloride and AICAR, which block glycolysis, induce HIF-1α and activate AMPK, respectively, resulted in an increase in CD1d-mediated NKT-cell responses. . Proposed model illustrating the mechanisms by which AMPK functions as a central metabolic switch that governs glucose and lipid metabolism and activation of this master switch serves as a danger signal to alert NKT cells to infection and malignancy. Once activated, AMPK reduces plasma insulin levels, suppresses ATPconsuming metabolic functions (such as synthesis of fatty acids, sterols, glycogen and proteins) and increases ATP-producing activities (such as glucose uptake, fatty acid oxidation and mitochondrial biogenesis) to restore energy homeostasis. In this study, antigen presenting cells were pretreated with 2DOG, cobalt chloride, AICAR, A769662 and metformin to targeted several steps in this pathway, as indicated with red arrows, and found an enhanced CD1d-mediated NKT-cell activation. These data suggest that targeting cellular metabolism may serve as a novel means of inducing innate immune responses.
These data suggest that targeting cellular metabolism may serve as a novel means of inducing innate immune responses. NKT cells comprise an important subset of T cells that are activated by glycolipid antigens within the context of CD1d (Terabe and Berzofsky 2014). Given their potential high therapeutic significance, NKT-cell-based clinical trials have been conducted in patients with advanced non-small cell lung cancers and with head and neck cancers (reviewed in Fujii et al. 2013) . However, the mechanisms by which NKT cells discriminate between healthy normal cells and cancerous or infected cells remain unclear. Consequently, in our studies, we have primarily focused our efforts on delineating the underlying mechanism(s) by which NKT cells recognize and destroy these targets, in order to make progress on the development of effective NKT-cellbased therapeutic strategies.
In our previous study examining the role of Bcl-xL in CD1d-mediated antigen presentation, we found that there was increased levels of Rab7 after Bcl-xL knockdown compared to the scrambled control (Subrahmanyam, Carey and Webb 2014) . These data suggest that knocking down Bcl-xL leads to upregulation of Rab7 and an expansion of the late endosomal compartment, acting as a depot for CD1d molecules and resulting in impaired trafficking to the lysosomal compartment, and further implicates a role for autophagy in regulating antigen presentation. AMPK promotes autophagy (Dong et al. 2016) ; thus, in this study, we investigated the role of AMPK on CD1d-dependent NKT-cell responses.
While other studies have examined the role of metabolism on T-cell responses (Tamas et al. 2006; Palmer et al. 2015) , we have focused on its role in antigen processing and presentation. Specifically, AMPK suppresses mTOR-dependent transcriptional regulators (such as cyclin D1 and myc) to inhibit cell growth and tumorigenesis. Two mTORC1-regulated transcription factors involved in cell growth are the sterol-regulatory element-binding protein 1 and HIF1. The HIF subunits are stabilized through the hypoxic inactivation of the von Hippel-Lindau E3 ligase that targets them for destruction. Conditions that lower intracellular ATP levels; for example, low glycolytic rates from low glucose concentrations or inhibitors, such as 2DOG, can lead to the activation of AMPK in a LKB1-dependent manner. Importantly, we have found that pretreatment of antigen presenting cells with 2DOG, CoCl 2 and AICAR all result in increased NKT-cell activation, highlighting the importance of targeting these pathways. Our proposed model is shown in Fig. 6 .
It has been well established that tumor metabolism is significantly different compared to normal cells and is characterized by an increase in the utilization of glycolysis, even in the presence of an adequate oxygen supply (the Warburg Effect) (Semenza 2007) . Additionally, the microenvironment surrounding tumors is typically poorly vascularized and causes low levels of oxygen near the tumor. A number of proteins, specifically HIF1-α and AMPK, are upregulated under conditions of hypoxia. These proteins control the transcriptional regulation of over 100 different proteins responsible for glucose metabolism, lipid metabolism and a diverse set of other functions. In order to assess the potential role of these pathways on CD1d-mediated NKT-cell responses, we used pharmacological agents to induce HIF and AMPK, and found that both resulted in an increase in CD1d-dependent NKT-cell activation. Taken together, our data suggest that stressors such as certain viral infections and cancers induce alter cellular bioenergetics leading to a switch in oxidative respiration. We believe that this alters the repertoire of endogenous glycolipid antigens presented by CD1d molecules to NKT cells, thereby acting as a danger signal and enhancing NKT-cell-mediated effector responses. Ongoing studies are focused on characterizing the changes in the lipid profiles, as well as identifying pharmacological agents that enhance CD1d-mediated NKT-cell responses.
It has been reported that patients who are currently taking metformin, a classic activator of AMPK responsible for decreasing circulating glucose levels by blocking complex I of the electron transport chain, are at a significantly decreased risk of developing certain types of cancer (Mayer, Klotz and Venkateswaran 2015) . Because this phenomenon correlates with generating a hypoxic state in tumor cells, we wished to investigate if similar hypoxia-inducing compounds would increase immunologic cell activity, specific NKT cells, in vitro. We found that treatment of antigen presenting cells (APCs) with agents that alter metabolism such as, 2DOG, CoCl 2 , and AICAR, followed by coculture with NKT cells, causes an increase in NKT-cell cytokine secretion. Additionally, we observed an increase in AMPK and well as pAMPK transcription. Taken together, our studies implicate a novel role for metabolism in enhancing the innate immune response. Furthermore, we posit that activating AMPK by repurposing FDA-approved drugs, such as metformin, has the potential to revolutionize treatment regimens, by replacing interventions that have life-threatening toxicities with ones that are safe and effective.
